| SEVERE DYSHIDROTIC ECZEMA AFTER INTRAVENOUS IMMUNOGLOBULIN THERAPY FOR KAWASAKI SYNDROME. | |
| | |
MedLine Citation:
|
PMID: 22304420 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Dyshidrotic eczema is one of the rare cutaneous adverse effects of intravenous immunoglobulin therapy, usually seen in adults. We herein report the first pediatric case of severe dyshidrotic eczema occurring after intravenous immunoglobulin therapy for Kawasaki syndrome. |
| | |
Authors:
|
Takahisa Shiraishi; Toshiyuki Yamamoto |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-2-3 |
Journal Detail:
|
Title: Pediatric dermatology Volume: - ISSN: 1525-1470 ISO Abbreviation: - Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-2-6 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8406799 Medline TA: Pediatr Dermatol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2012 Wiley Periodicals, Inc. |
Affiliation:
|
Department of Dermatology, Fukushima Medical University, Fukushima, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Diversity of flavin-binding monooxygenase genes (almA) in marine bacteria capable of degradation lon...
Next Document: Recognition of Facial Expressions of Emotion in Adults with Down Syndrome.